CIRM’s CLIN2 funding program will support the completion of phase 1, 2, or 3 clinical trials— including pivotal trials— for regenerative medicine therapies that address significant unmet medical needs ...
The goal of this project was to improve the long-term performance of clinical-grade expanded polytetrafluoroethylene (ePTFE) vascular grafts by coating them with a peptide ligand called LXW7. LXW7 is ...
The objective of this project was to file an Investigational New Drug (IND) application for a clinical trial using embryonic stem cell-derived neural stem cells to treat patients with Huntington’s ...
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
NysnoBio is advancing a gene therapy for Parkinson’s Disease based on human genetic data indicating the Parkin protein is a regenerative factor for neurons that die in Parkinson’s Disease (PD).
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
ALS (amyotrophic lateral sclerosis) is a devastating disease that progressively destroys the nerve cells that control movement, eventually taking away a person’s ability to walk, speak, swallow, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results